You are here

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.

 

Online download statistics by month:

Online download statistics by month: December 2022 to June 2025

AbstractFullPdf
Dec 202218118456
Jan 202313631378379
Feb 2023288295113
Mar 202324124699
Apr 202314014871
May 202315015180
Jun 202313714065
Jul 202311812366
Aug 202311311553
Sep 2023929347
Oct 202312612883
Nov 20239810057
Dec 202314314397
Jan 2024147151115
Feb 202412712784
Mar 2024129129115
Apr 2024166166112
May 202417217593
Jun 202416216497
Jul 202415215474
Aug 2024959457
Sep 2024118121244
Oct 202414014075
Nov 202412913277
Dec 202418018281
Jan 202511611878
Feb 202519519673
Mar 2025175176124
Apr 2025173174101
May 2025134138110
Jun 2025757743
Total577558583019